Efficacy of α-Lipoic Acid Against Diabetic Cataract in Rat
- 134 Downloads
α-Lipoic acid (LA) is well known as a powerful antioxidant. The efficacy of dihydrolipoate-LA for oral administration against streptozotocin (STZ)-induced diabetic cataract in rat was investigated.
Rats were divided into three groups, control, diabetes mellitus (DM), and DM treated with LA (DM+LA). Diabetes was induced by intravenous injection of 50 mg/kg STZ. DM+LA rats were fed 30 mg/rat per day LA in their diet. Lens changes were assessed using Scheimpflug images (EAS-1000) and by measuring light-scattering intensity.
Increase in lens light scattering was less (P < 0.05) in DM+LA rats than in DM rats 5 weeks after induction of diabetes. DM rats had the highest and control rats the lowest blood glucose levels at every measurement point up to 111 days (P < 0.05).
LA treatment delayed development and progression of cataract in rats with streptozotocin-induced diabetes. Jpn J Ophthalmol 2007;51:10–13 © Japanese Ophthalmological Society 2007
Key wordsantioxidant diabetic cataract α-lipoic acid lipoic acid rat
Unable to display preview. Download preview PDF.
- 17.Coppey, LJ, Gellett, JS, Davidson, EP, Dunlap, JA, Lund, DD, Yorek, MA 2001Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerveDiabetes5019271937PubMedGoogle Scholar